Ekkehard Dikomey - Wissenschaftliche Veröffentlichungen

(1 - 17 von 17

)

Dr. Sonja Strunz - SBI Rostock

www.sbi.uni-rostock.de

I am interested in analyzing radiation-induced changes in transcriptional responses and in biomarker discovery for radiation dose prediction.

Toxicology | DNA Repair in Toxicology | ScienceDirect.com by Elsevier

www.sciencedirect.com

Ekkehard Dikomey, Kerstin Borgmann, Ingo Brammer, Ulla Kasten-Pisula. Pages : Download PDF. Article preview. Research articleFull text access ...

Association between SNPs in defined functional pathways and risk of...

www.ikmb.uni-kiel.de

IKMB. Search form. Search . RSS Kerstin Borgmann, Andreas Ziegler, Cordula Petersen, Ekkehard Dikomey, Ulrike Hoeller. Year of publication: Volume: -Issue

Association of single nucleotide polymorphisms in the genes ATM,...

www.ikmb.uni-kiel.de

... Sebastian Reuther, Silke Szymczak, Kerstin Borgmann, Ulrike Hoeller, Andreas Ziegler, Cordula Petersen, Ekkehard Dikomey. Year of publication: ...

Aus dem Labor für Strahlenbiologie & Experimentelle ...

ediss.sub.uni-hamburg.de

Aus dem Labor für Strahlenbiologie & Experimentelle Radioonkologie (Leiter Prof. Dr. Ekkehard Dikomey) der Klinik für Strahlentherapie und Radioonkologie

Aktuelles - GSI.dewww.gsi.de › work › forschung › biophysik › kvsf › aktuelles

www.gsi.de

Prof. Dr. Ekkehard Dikomey (Sprecher des KVSF und ehemaliger Leiter des Labors für Strahlenbiologie & Experimentelle Radioonkologie) erhält den Life Science ...

Universität Hamburg

www.stine.uni-hamburg.de

Dr. Ekkehard Dikomey. 2, Mo, 21. Okt , 14:15, 15:45, Campus Lehre (N 55), Raum , UKEDr. Florian Cremers; Prof. Dr. Ekkehard ...

Partners - SBI Rostock

www.sbi.uni-rostock.de

Ekkehard Dikomey. Strahlenbiologie und Experimentelle Radioonkologie, Universitätsklinikum Hamburg-Eppendorf. Website. Georg Iliakis. Institute of Medical ...

Gene defect as a potential gateway for targeted prostate cancer...

www.sciencedaily.com

The loss of CHD1, one of the most frequently mutated genes in prostate tumors, sensitizes human prostate cancer cells to different drugs, including PARP...